Detection of Intracellular Complement Activation in Human T Lymphocytes: Version 1
- PMID: 39013047
- Bookshelf ID: NBK604940
- DOI: 10.17917/Y4CQ-SV79
Detection of Intracellular Complement Activation in Human T Lymphocytes: Version 1
Excerpt
The complement present in plasma is a group of approximately 30 proteins which are produced by the liver. Plasma complement plays an important role in innate immunity and promotes adaptive immunity against pathogens. Activation of plasma complement may occur in response to a drug product. Such undesirable activation results in immediate-type hypersensitivity reactions independent of immunoglobulin E. These reactions are often referred to as Complement Activation Related Pseudoallergy (CARPA). Although CARPA has been observed in the clinic with various types of drug products, nanoformulations, and especially PEGylated liposomes, are frequent causes of CARPA in patients [1, 2].
Activation of plasma complement is initiated via three main pathways, the classical, the alternative and the lectin pathway, all of which converge at the complement component 3 (C3) to form a common, terminal pathway leading to the formation of the membrane attack complex [3]. Cleavage of C3, C4 and C5 components of the plasma complement results in generation of several split products, C3a, C4a, and C5a, which are also known as anaphylatoxins. The anaphylatoxins are the main triggers of the symptoms observed in CARPA. The larger split products (C3b, C4b, and C5b) are opsonins which bind to and accelerate the clearance of pathogens.
Recently, the concept of complement has been expanded to include so-called intracellular complement [4]. The complement protein C3 has been found in many cells including lymphocytes, monocytes, endothelial and even cancer cells. The activation of intracellular complement generates split products which are exported from the cell onto the membrane. Since the activation of intracellular complement in T-lymphocytes was found to correlate with autoimmune disorders [4], and growing evidence is available for the involvement of T-lymphocytes in the development of drug-induced hypersensitivity reactions [5], understanding the ability of nanomaterials to activate intracellular complement may aid in establishing long-term safety profiles for these materials.
Sections
- 1. Introduction
- 2. Principles
- 3. Reagents, Materials, and Equipment
- 4. Reagent and Control Preparation
- 5. Isolation of Human PBMC
- 6. Treatment with Nanoparticles and Controls
- 7. Preparation of Cells for Flow Cytometry
- 8. Flow Cytometry
- 9. Data Analysis and Report
- 10. Acceptance Criteria
- 11. References
Similar articles
-
Detection of Intracellular Complement Activation by Nanoparticles in Human T Lymphocytes.Methods Mol Biol. 2024;2789:109-120. doi: 10.1007/978-1-0716-3786-9_11. Methods Mol Biol. 2024. PMID: 38506996
-
Activation of complement component C5: comparison of C5 convertases of the lectin pathway and the classical pathway of complement.J Biol Chem. 2008 Mar 21;283(12):7853-63. doi: 10.1074/jbc.M707591200. Epub 2008 Jan 18. J Biol Chem. 2008. PMID: 18204047
-
Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids.Anal Biochem. 1984 Jan;136(1):75-88. doi: 10.1016/0003-2697(84)90308-7. Anal Biochem. 1984. PMID: 6711816
-
Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.Transplant Proc. 1977 Mar;9(1):729-39. Transplant Proc. 1977. PMID: 325806 Review.
-
Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4.Int Immunopharmacol. 2001 Mar;1(3):365-92. doi: 10.1016/s1567-5769(01)00019-4. Int Immunopharmacol. 2001. PMID: 11367523 Review.
References
-
- Szebeni J, Alving CR, Rosivall L et al..: Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles. J Liposome Res 17(2), 107–117 (2007). - PubMed
-
- Salvador-Morales C, Sim RB: Complement activation. In: Handbook of immunological properties of engineered nanomaterials, Dobrovolskaia MA, Mcneil SE (Eds). World Scientific, Singapore: 357–384 (2013).
-
- Sahu A, Lambris JD: Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev 180, 35–48 (2001). - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous